| William B Brandenberger, MD | |
|
163 Van Buren Rd, Caribou, ME 04736-3567 | |
| (207) 492-3451 | |
| (207) 498-1392 |
| Full Name | William B Brandenberger |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 163 Van Buren Rd, Caribou, Maine |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134140296 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 015507 (Maine) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| William B Brandenberger, MD Po Box 40, Caribou, ME 04736-0040 Ph: (207) 498-2350 | William B Brandenberger, MD 163 Van Buren Rd, Caribou, ME 04736-3567 Ph: (207) 492-3451 |
News Archive
Baylor Health Care System ("Baylor") and Select Medical Corporation ("Select") today announced that they have received notification from the Office of the Attorney General of the State of Texas that it has completed its review of the proposed joint venture between affiliates of Baylor and Select and does not oppose the joint venture.
Following President Barack Obama's announcement of the New Alliance for Food Security and Nutrition at a food security summit last week, "USAID launched a Food Security Open Data Challenge that invites technologists, agriculture stakeholders, entrepreneurs, academics, and others to determine the most creative and wide-reaching use of open data for food security solutions and better, cheaper, and faster results," Maura O'Neill, chief innovation officer at USAID, and Kat Townsend, special assistant for engagement at USAID, write in a post in the agency's "DipNote" blog (5/27).
AbbVie, a global biopharmaceutical company, today announced that it will advance ABT-494, its internally developed investigational selective JAK1 inhibitor, to Phase 3 studies in rheumatoid arthritis. Following a thorough review of available data, AbbVie will not exercise its right to in-license the Galapagos JAK1 inhibitor, filgotinib.
Some of us who are hospitalized are feeling worse rather than better. On average, seven percent of all patients in industrial countries are affected by "nosocomial" infections. In intensive care units, the risk increases even more. This can result in serious illnesses and life-threatening blood poisoning.
Data show that young adult women in the United States have high rates of sexually transmitted infections (STIs) that increase their risk of HIV. Though epidemiologic and behavioral factors for risk have been studied, we know very little about brain factors that may be linked to STI/ HIV sexual risk.
› Verified 6 days ago
Dr. Kevin Frederick Strong, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 163 Van Buren Rd, Caribou, ME 04736 Phone: 207-492-3451 Fax: 207-498-1697 | |
Farhana Ahmad, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 163 Van Buren Rd, Caribou, ME 04736 Phone: 207-492-3451 Fax: 207-498-1697 | |
Kathryn Rutledge, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 163 Van Buren Rd, Caribou, ME 04736 Phone: 207-492-3451 Fax: 207-498-1392 |